We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$104M
Cap. Flow
+$114M
Cap. Flow %
52.89%
Top 10 Hldgs %
3.25%
Holding
1,960
New
575
Increased
592
Reduced
190
Closed
602

Top Buys

Rank Stock Value
1
PLAB icon
Photronics
PLAB
+$919K
2
ALXO icon
ALX Oncology
ALXO
+$905K
3
EYPT icon
EyePoint Inc
EYPT
+$814K
4
MGNX icon
MacroGenics
MGNX
+$773K
5
CMPS
Compass Pathways
CMPS
+$725K

Top Sells

Rank Stock Value
1
STRO icon
Sutro Biopharma
STRO
+$394K
2
RIOT icon
Riot Platforms
RIOT
+$366K
3
REVG
REV Group
REVG
+$362K
4
TSHA icon
Taysha Gene Therapies
TSHA
+$353K
5
PBYI icon
Puma Biotechnology
PBYI
+$329K

Sector Composition

Rank Sector Weight
1 Healthcare 18.55%
2 Technology 15.83%
3 Industrials 15.4%
4 Financials 12.94%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAP icon
1801
SAP
SAP
$248B
– –
-26
Closed -$5.07K
SAR icon
1802
Saratoga Investment
SAR
$284M
– –
-398
Closed -$9.23K
FLNA
1803
Filana Therapeutics
FLNA
$39.6M
– –
-2,297
Closed -$46.6K
SBGI icon
1804
Sinclair Inc
SBGI
$999M
– –
-4,001
Closed -$53.9K
SBUX icon
1805
Starbucks
SBUX
$119B
– –
-1,765
Closed -$161K
SCS
1806
DELISTED
Steelcase
SCS
– –
-879
Closed -$11.5K
SEDG icon
1807
SolarEdge
SEDG
$2.1B
– –
-902
Closed -$64K
SEE
1808
DELISTED
Sealed Air
SEE
– –
-3,200
Closed -$119K
SES icon
1809
SES AI
SES
$187M
– –
-52,313
Closed -$87.9K
SF
1810
Stifel
SF
$12.3B
– –
-281
Closed -$14.6K
SFIX
1811
Stitch Fix
SFIX
$407M
– –
-67,981
Closed -$179K
SHC icon
1812
Sotera Health
SHC
$5.39B
– –
-19,181
Closed -$230K
SHG icon
1813
Shinhan Financial Group
SHG
$38.6B
– –
-811
Closed -$28.8K
SHOO icon
1814
Steven Madden
SHOO
$3.2B
– –
-1,905
Closed -$80.5K
SIGA icon
1815
SIGA Technologies
SIGA
$236M
– –
-12,986
Closed -$111K
SKM icon
1816
SK Telecom
SKM
$14.9B
– –
-853
Closed -$18.4K
SLG icon
1817
SL Green Realty
SLG
$3.94B
– –
-192
Closed -$10.6K
SLGN icon
1818
Silgan Holdings
SLGN
$4.35B
– –
-160
Closed -$7.77K
SLNO
1819
DELISTED
Soleno Therapeutics
SLNO
– –
-135
Closed -$5.78K
SLRC icon
1820
SLR Investment Corp
SLRC
$686M
– –
-1,375
Closed -$21.1K
SLVM icon
1821
Sylvamo
SLVM
$1.43B
– –
-112
Closed -$6.92K
SMMT icon
1822
Summit Therapeutics
SMMT
$14B
– –
-24,186
Closed -$100K
SN icon
1823
SharkNinja
SN
$24.4B
– –
-148
Closed -$9.22K
SNBR
1824
DELISTED
Sleep Number
SNBR
– –
-16,212
Closed -$260K
SNCY
1825
DELISTED
Sun Country Airlines
SNCY
– –
-19,820
Closed -$299K
71 72
73
74 75

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
T
TOBAM Paris, France $412M AUM 18.33% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return

EntryPoint Capital's Q2 2024 Portfolio in Review

As of Q2 2024, EntryPoint Capital held 1,960 positions worth $215M, up 93% from $112M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

EntryPoint Capital deployed $114M of net new capital in Q2 2024, opening 575 new positions and adding to 592 existing holdings. Its largest new stake was EyePoint Inc: 58,291 shares worth $507K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Oscar Health, an estimated $327K trimmed.

  • EntryPoint Capital's largest Q2 2024 buy was EyePoint Inc: 58,291 shares worth $507K.
  • EntryPoint Capital added most to Photronics in Q2 2024, an estimated $919K increase.
  • EntryPoint Capital's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $327K.
  • EntryPoint Capital fully exited Sutro Biopharma in Q2 2024, selling an estimated $394K.
  • EntryPoint Capital's ten largest holdings make up 3.3% of its $215M portfolio in Q2 2024.
  • EntryPoint Capital opened 575 new positions and closed 602 in Q2 2024.
  • EntryPoint Capital's portfolio value rose 93% quarter-over-quarter to $215M.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.